Diversionary Politics and Territorial Disputes: Evidence from Turkish Airspace Incursions
Foreign Policy Analysis · 30.03.2021 · 17 (3)
DOI: 10.1093/fpa/orab007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foreign Policy Analysis, online erschienen am 17.03.2021. Verfasst von Marius Mehrl und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Diversionary theories of interstate conflict suggest that domestic problems push leaders to initiate hostilities against foreign foes in order to garner support. However, the empirical support for this proposition is mixed as critics point out that leaders should not start conflicts that can be extremely costly for them, potentially even removing them from office. We propose that while leaders may not initiate new conflicts, they do tap into existing territorial disputes when facing internal disapproval. That is, they engage in material acts of foreign policy showing domestic audiences that they defend or emphasize their country's claim while being unlikely to result in full-scale armed confrontations. To test this claim, we use monthly data, covering the period 2013–2020, on leader approval and incursions into contested airspace from Turkey's long-standing territorial dispute with Greece. Results from time-series models offer support for our expectation.
Zitieren
APA
Mehrl, M., & Choulis, I. (2021). Diversionary Politics and Territorial Disputes: Evidence from Turkish Airspace Incursions. Foreign Policy Analysis, 17(3). https://doi.org/10.1093/fpa/orab007
Vancouver
Mehrl M, Choulis I. Diversionary Politics and Territorial Disputes: Evidence from Turkish Airspace Incursions. Foreign Policy Analysis. 2021;17(3). doi:10.1093/fpa/orab007
BibTeX
@article{Mehrl2021,
author = {Mehrl, Marius and Choulis, Ioannis},
title = {Diversionary Politics and Territorial Disputes: Evidence from Turkish Airspace Incursions},
journal = {Foreign Policy Analysis},
year = {2021},
volume = {17},
number = {3},
doi = {10.1093/fpa/orab007}
}
EUVIMED